Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2003;34:2187-2194
Published online before print July 31, 2003, doi: 10.1161/01.STR.0000085084.15144.66
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
34/9/2187    most recent
01.STR.0000085084.15144.66v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cardoso, C. R.L.
Right arrow Articles by Deccache, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cardoso, C. R.L.
Right arrow Articles by Deccache, W.
Related Collections
Right arrow Cerebrovascular disease/stroke
Right arrow Electrocardiology
Right arrow Type 2 diabetes
Right arrow Risk Factors for Stroke

(Stroke. 2003;34:2187.)
© 2003 American Heart Association, Inc.


Original Contributions

QTc Interval Prolongation Is a Predictor of Future Strokes in Patients With Type 2 Diabetes Mellitus

Claudia R.L. Cardoso, MD, PhD; Gil F. Salles, MD Waldemar Deccache, MD, PhD

From the Department of Internal Medicine, Clementino Fraga Filho University Hospital, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.

Correspondence to Claudia R.L. Cardoso, Rua Cróton 72, Jacarepagua, CEP 22750–240, Rio de Janeiro, Brasil. E-mail claudiacardoso{at}hucff.ufrj.br

Background and Purpose— QTc interval prolongation is a predictor of cardiovascular morbidity and mortality in general populations and in patients with diabetes. The aim of this study was to investigate the predictors of stroke in patients with type 2 diabetes, with particular emphasis on the independent role of QT interval parameters.

Methods— We carried out a long-term follow-up study with 471 type 2 diabetics. Several clinical, laboratory, ECG, and echocardiographic variables were recorded at baseline. Predictive factors for stroke were evaluated by Kaplan-Meier estimation of survival curves and by univariate and multivariate Cox survival analyses.

Results— After a median follow-up of 57 months (range, 2 to 84 months), 40 incident strokes were observed. QTc interval prolongation (>=470 ms1/2) was an independent predictor of stroke, with adjusted hazard ratios ranging from 2.2 to 2.9 (95% confidence intervals, 1.1 to 6.0). Other independent factors associated with stroke were older age; the presence of cerebrovascular disease at baseline; increased 24-hour proteinuria, serum triglycerides, and left ventricular mass; and decreased high-density lipoprotein cholesterol. Excluding patients with previous cerebrovascular disease from the analysis did not change the results significantly.

Conclusions— QTc interval prolongation is a predictor of future stroke in patients with type 2 diabetes. Intervention studies are needed to assess whether this factor could be modified.


Key Words: diabetes mellitus • electrocardiography • risk factors • stroke




This article has been cited by other articles:


Home page
CirculationHome page
S. S. Chugh, K. Reinier, T. Singh, A. Uy-Evanado, C. Socoteanu, D. Peters, R. Mariani, K. Gunson, and J. Jui
Determinants of Prolonged QT Interval and Their Contribution to Sudden Death Risk in Coronary Artery Disease: The Oregon Sudden Unexpected Death Study
Circulation, February 10, 2009; 119(5): 663 - 670.
[Abstract] [Full Text] [PDF]


Home page
Postgrad. Med. J.Home page
J M Pappachan, J Sebastian, B C Bino, K Jayaprakash, K Vijayakumar, P Sujathan, and L A Adinegara
Cardiac autonomic neuropathy in diabetes mellitus: prevalence, risk factors and utility of corrected QT interval in the ECG for its diagnosis
Postgrad. Med. J., April 1, 2008; 84(990): 205 - 210.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Xiao, X. Luo, H. Lin, Y. Zhang, Y. Lu, N. Wang, Y. Zhang, B. Yang, and Z. Wang
MicroRNA miR-133 Represses HERG K+ Channel Expression Contributing to QT Prolongation in Diabetic Hearts
J. Biol. Chem., April 27, 2007; 282(17): 12363 - 12367.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
G. F. Salles, K. V. Bloch, and C. R.L. Cardoso
Mortality and Predictors of Mortality in a Cohort of Brazilian Type 2 Diabetic Patients
Diabetes Care, June 1, 2004; 27(6): 1299 - 1305.
[Abstract] [Full Text] [PDF]